T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$2.16B |
| 2 |
GE Aerospace
GE
|
+$1.93B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$1.62B |
| 4 |
Eli Lilly
LLY
|
+$1.59B |
| 5 |
SPLK
Splunk Inc
SPLK
|
+$1.38B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.72B |
| 2 |
Booking.com
BKNG
|
+$2.61B |
| 3 |
RHT
Red Hat Inc
RHT
|
+$1.62B |
| 4 |
JPMorgan Chase
JPM
|
+$1.43B |
| 5 |
State Street
STT
|
+$1.29B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.46% |
| 2 | Technology | 17.53% |
| 3 | Financials | 14.18% |
| 4 | Consumer Discretionary | 14.02% |
| 5 | Communication Services | 9.56% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GTHX
976
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $32.5M | 0.01% |
1,699,199
-242,213
| -12% | -$9.07M |
|
977
ACI Worldwide
ACIW
$5.33B
| $32.5M | 0.01% |
1,172,949
+187,762
| +19% | +$5.08M |
|
|
CIR
978
DELISTED
CIRCOR International, Inc
CIR
| $32.4M | 0.01% |
1,520,918
+4,302
| +0.3% | +$143K |
|
|
NBL
979
DELISTED
Noble Energy, Inc.
NBL
| $32.3M | 0.01% |
1,722,238
+29,735
| +2% | +$761K |
|
|
EVOP
980
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $32.2M | 0.01% |
1,304,712
-448,403
| -26% | -$11.1M |
|
981
Ironwood Pharmaceuticals
IRWD
$714M
| $32M | 0.01% |
3,690,875
-6,964,363
| -65% | -$79.9M |
|
982
Middleby
MIDD
$5.38B
| $31.9M | 0.01% |
310,665
-37,632
| -11% | -$4.28M |
|
983
Champion Homes
SKY
$5.23B
| $31.8M | 0.01% |
2,165,232
+127,618
| +6% | +$2.82M |
|
984
Theravance Biopharma
TBPH
$878M
| $31.6M | 0.01% |
1,233,062
-363,125
| -23% | -$9.8M |
|
|
VSM
985
DELISTED
Versum Materials, Inc.
VSM
| $31.5M | 0.01% |
1,137,561
-1,529
| -0.1% | -$48.3K |
|
986
Generac Holdings
GNRC
$13.1B
| $31.4M | 0.01% |
632,675
+25,184
| +4% | +$1.35M |
|
|
TVRD
987
Tvardi Therapeutics
TVRD
$22.1M
| $31.4M | 0.01% |
67,097
-48
| -0.1% | -$31K |
|
|
DISH
988
DELISTED
DISH Network Corp.
DISH
| $31.2M | 0.01% |
1,250,198
+856,048
| +217% | +$26.9M |
|
989
Virtus Investment Partners
VRTS
$1.12B
| $31.1M | 0.01% |
392,072
+9,498
| +2% | +$922K |
|
990
Oceaneering
OII
$5.08B
| $31M | 0.01% |
2,560,943
+57,205
| +2% | +$1.08M |
|
991
Brown-Forman Class B
BF.B
$12.8B
| $31M | 0.01% |
651,073
+5,337
| +0.8% | +$254K |
|
992
Repligen
RGEN
$9.45B
| $30.7M | 0.01% |
582,014
+39,591
| +7% | +$2.32M |
|
|
NCI
993
DELISTED
Navigant Consulting, Inc.
NCI
| $30.7M | 0.01% |
1,275,642
-524,466
| -29% | -$12M |
|
994
Addus HomeCare
ADUS
$2.2B
| $30.7M | 0.01% |
451,772
+150,092
| +50% | +$10.3M |
|
995
Hercules Capital
HTGC
$3.11B
| $30.6M | 0.01% |
2,771,861
-81,912
| -3% | -$999K |
|
996
Cirrus Logic
CRUS
$6.11B
| $30.5M | 0.01% |
917,821
+802
| +0.1% | +$29.8K |
|
|
DNB
997
DELISTED
Dun & Bradstreet
DNB
| $30.3M | 0.01% |
212,035
-1,672
| -0.8% | -$238K |
|
|
SBT
998
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
| $30.3M | 0.01% |
4,353,967
+290,145
| +7% | +$2.72M |
|
|
ORTX
999
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $30.1M | 0.01% |
+191,153
| New | +$28.5M |
|
1000
RenaissanceRe
RNR
$13.2B
| $30.1M | 0.01% |
224,797
-22,069
| -9% | -$2.88M |
|
Similar funds
T. Rowe Price Associates's Q4 2018 Portfolio in Review
As of Q4 2018, T. Rowe Price Associates held 2,656 positions worth $591B, down 14% from $685B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
T. Rowe Price Associates's Q4 2018 filing shows 75 new, 1,551 increased, 819 reduced and 97 closed positions. Its largest new stake was StoneCo: 28,883,228 shares worth $519M. The largest sale was Tesla, an estimated $2.72B.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
- T. Rowe Price Associates's largest Q4 2018 buy was StoneCo: 28,883,228 shares worth $519M.
- T. Rowe Price Associates added most to Meta Platforms (Facebook) in Q4 2018, an estimated $2.16B increase.
- T. Rowe Price Associates's biggest Q4 2018 reduction was Tesla, cutting an estimated $2.72B.
- T. Rowe Price Associates fully exited Aetna Inc in Q4 2018, selling an estimated $600M.
- T. Rowe Price Associates's ten largest holdings make up 20% of its $591B portfolio in Q4 2018.
- T. Rowe Price Associates opened 75 new positions and closed 97 in Q4 2018.
- T. Rowe Price Associates's portfolio value fell 14% quarter-over-quarter to $591B.
Based on T. Rowe Price Associates's 13F filing for Q4 2018, filed 14 Feb 2019.